Background: Palliative care (PC) contributes to improved end-of-life care for patients with hematologic malignancies (HM) and solid tumors (ST) by addressing physical and psychological symptoms and spiritual needs. Research on PC in HM vs. ST patients is fragmented and suggests less use. Methods: We analyzed claims data of all deceased members of a large German health insurance provider for the year before death. First, we analyzed the frequency and the beginning of different types of PC and compared patients with HM vs. ST. Second, we analyzed the adjusted impact of PC use on several end-of-life quality outcomes in patients with HM vs. ST. We performed simple and multiple (logistic) regression analysis, adjusted for relevant covariates, and standardized for age and sex. Results: Of the 222,493 deceased cancer patients from 2016 to 2020, we included 209,321 in the first analysis and 165,020 in the second analysis. Patients with HM vs. ST received PC less often (40.4 vs. 55.6%) and later (34 vs. 50 days before death). PC use significantly improved all six quality indicators for good end-of-life care. HM patients had worse rates in five of the six indicators compared with ST patients. Interaction terms revealed that patients with ST derived greater benefit from PC in five of six quality indicators than those with HM. Conclusion: The data highlight the need to integrate PC more often, earlier, and more effectively into the care of patients with HM.
Background: The COVID-19 pandemic has affected health care systems worldwide. Multidisciplinary teams provide specialist palliative home care (SPHC) for patients with incurable, severe, progressive diseases. These patients are at the same time at high risk, if infected, highly constricted by containment measures, and dependent on support. Aim: To explore i) how German SPHC teams were affected by the pandemic during the first wave, ii) which challenges they faced, and iii) which strategies helped to handle the consequences of the COVID-19 pandemic for providing good SPHC. Method: Four focus groups (with representatives of 18 SPHC teams) and five guided interviews with stakeholders were conducted and analysed using qualitative content analysis. Results: Seven key categories emerged from the data. A category in the background describes dependence on organizational characteristics (e.g. sponsorship), which varied by regional factors. Information management was a challenge to SPHC teams, as they had to collect, interpret and adapt, and disseminate information. They reported a shift in patient care because of the COVID-19 pandemic, due to restricted home visits, visitation ban in nursing homes, and difficulties for hospital, hospice and nursing home admissions. Measures to reduce risk of infection impeded teamwork. Teams relied upon their local networks in crisis management, but felt often overlooked by local health authorities. Their respective SPHC state associations supported them in information management and exchange. Discussion: The pandemic has severely impacted home care for especially vulnerable seriously ill and dying people. A good network with local health providers and authorities could help to harmonize local regulations and ensure quality care for all patient groups. SPHC teams could play an important role in caring for palliative patients with COVID-19 who are not admitted to a hospital due to preferences or resources.
Purpose: Patients with hematologic malignancies (HM) receive palliative care (PC) less often and later than patients with solid tumors (ST). Patients’ lack of knowledge about PC and negative feelings about PC are barriers to their willingness to use PC. Is there a difference between patients with HM and ST in their knowledge and willingness to use PC? Methods: Two hundred ten patients (85 HM, 125 ST) from an oncology day clinic at a university hospital participated in this cross-sectional, questionnaire-based survey. Results: Patients with HM and ST had high knowledge and mainly positive feelings about PC. More than half of the patients answered that they would feel reassured by the use of PC, and one-third would feel anxious or hopeless. The majority of patients (58.3%) were willing to use PC. There are no significant differences between patients with HM and ST. In multiple regression analysis, perceived chance of cure and feelings of reassurance and anxiety are associated with willingness to use PC, but not with the HM/ST disease group. More than half (53.9%) of the participants would like the treating physician to choose the timing of a discussion about PC. Conclusion: Our study shows a high level of knowledge and relatively positive feelings of patients about PC, with no differences between patients with HM or ST. They expect their treating physician to initiate communication about PC. Communication should include the patient’s feelings about PC and their chances of a cure.
Integrating palliative care into the treatment of patients with advanced hematological malignancies (HM) remains challenging. To explore treating physicians’ perspectives on current palliative care practice and to evaluate factors influencing integration, we conducted a nationwide online survey. Based on literature and expert review, the survey addressed the importance of palliative care, communication about life-threatening conditions, challenges in establishing goals of care, and factors influencing the integration of palliative care. 207 physicians treating patients with HM in Germany participated. We used standard descriptive statistics to analyze quantitative data and a content structuring approach. Most physicians considered palliative care in HM to be very important (60.6%) and discussed life-threatening conditions with more than half of their patients (52%), especially when goals of care were changed (87.0%) or when patients raised the topic (84.0%). Disease-related factors, different professional perspectives on prognosis, and patient hopes were the main barriers to changing goals of care, but collaboration with colleagues and multidisciplinary teams provided important support. Time constraints were identified as the main barrier to integrating palliative care. The majority worked well with palliative care teams. Referral processes and conditions were perceived as minor barriers. The study highlights the need to address barriers to integrating palliative care into the management of patients with advanced HM. Future research should aim at optimizing palliative care for patients with HM.
Background: The COVID-19 pandemic confronted nursing homes with a variety of challenges to ensure the provision of palliative care for residents. PallPan-Implement aimed to adapt the recommendations of the National Strategy for the Care of Seriously Ill, Dying Adults and their Families in Times of Pandemic (PALLPAN) in such a way that nursing facilities can use and implement them. Methods: Based on 33 PALLPAN recommendations, we developed a questionnaire, conducted a pilot implementation for selected nursing homes, and asked for qualitative feedback. Results: The developed questionnaire contains 22 main questions. A three-stage pilot implementation with an introductory event, processing phase, and evaluation event took place in seven facilities. The facilities evaluated the developed questionnaire as helpful. Feedback from the facilities identified three major categories: (a) requirements for facilities should be realistic to avoid frustration, (b) the creation of a pandemic plan for palliative care only is impractical, (c) measures for the psychosocial support of staff is particularly necessary, but was perceived as difficult to implement. Conclusions: The practical implementation of recommendations requires a concept and material tailored to facilities and areas. The strategy of PallPan Implement developed in this project appears to be target-oriented, well-received, and can be recommended for further implementation.
Zusammenfassung: Ziel der Studie Die Studie erforscht die Auswirkungen der COVID-19 Pandemie und die zu ihrer Eindämmung erfolgten Maßnahmen auf die Tätigkeit der spezialisierten ambulanten Palliativversorgung (SAPV) aus Sicht der SAPV-Leitungspersonen. Methodik In dieser Querschnittsstudie wurde ein Onlinefragebogen mit quantitativen und qualitativen Fragen entwickelt und verwendet, der sich auf die Erfahrungen der SAPV in der ersten und zweiten Welle der COVID-19 Pandemie in Deutschland bezieht. In einem strukturierten Rekrutierungsprozess wurden alle SAPV-Teams (n=357) zur Teilnahme aufgefordert. Ergebnisse Vom 10.10.2020 bis 07.01.2021 nahmen 154 SAPV-Teams teil (Rücklaufquote 43%). Sie beschreiben deutliche Auswirkungen der COVID-19 Pandemie auf ihre Tätigkeit. Trotz pandemiebedingter Probleme der Personalverfügbarkeit (78,5%), konnte die Palliativversorgung der Patient*innen weitestgehend sichergestellt werden. Die Zahl der zu betreuenden Patient*innen blieb für die meisten Teams gleich, war für einige zunehmend und nur für wenige abnehmend. Zentral war die Umstellung der direkten Kontakte zu Patient*innen und deren Angehörigen auf telefonische Kontakte. Als zusätzlich erschwerend wurden die generelle Vermeidung von Kontakten, die Einhaltung von Hygienebestimmungen bei notwendigen persönlichen Kontakten und die pandemiebezogenen Unsicherheiten und Ängste sowohl im Team selbst, als auch bei Angehörigen und Patient*innen, angegeben. Die Beschaffung von Schutzausrüstung war in der ersten Welle eine Herausforderung. Probleme in der Zusammenarbeit mit Kooperationspartnern (z. B. stationäre Pflegeeinrichtungen und ambulante Hospizdienste) hatten sich im Pandemieverlauf abgebaut, waren jedoch in allen Bereichen größer als zuvor. Viele Maßnahmen zur Bewältigung der pandemischen Herausforderungen wurden umgesetzt, andere als sinnvoll aber nicht umgesetzt bewertet, weitere als nicht sinnvoll oder umsetzbar.Schlussfolgerungen SAPV-Teams berichten, dass es ihnen trotz der Notwendigkeit der Anpassung vieler Prozesse an die Situation der Pandemie gelungen ist, die Versorgung der Patient*innen, wenn auch unter erschwerten Bedingungen, aufrecht zu erhalten.